老虎证券

BUZZ-Australia's Neurotech International jumps as US FDA grants rare disease status for drug candidate

Reuters
2025/10/08
BUZZ-Australia's <a href="https://laohu8.com/S/NTI.AU">Neurotech International</a> jumps as US FDA grants rare disease status for drug candidate

** Shares of Australia's Neurotech International NTI.AX rise as much as 52.6% to A$0.029, their biggest intraday pct gain since early-July 2020

** Stock at its highest level since April 23

** NTI stock up 10.5% currently

** Biopharmaceutical co says U.S. FDA granted rare pediatric disease designation for drug candidate, NTI164, for treatment of Rett syndrome

** Rett syndrome is a rare genetic neurological and developmental disorder that affects ways in which brain develops

** Nearly 15.3 million shares change hands, 13.2x the 30-day average volume

** Stock has fallen 61.8% this year, as 0024 GMT

(Reporting by Roshan Thomas in Bengaluru)

((Roshan.Thomas@thomsonreuters.com))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10